Zydus Lifesciences sets Q2 FY27 results and earnings call for November 4

Board & Shareholder Meetings View source PDF Explain this filing

ZYDUSLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.3%Reaction day

₹1129.40

prior close

₹1129.40

announcement price

After-mkt

timing

Nifty 100market+0.7%+1.5% vs market

Pharmaceuticals peers, median of 174sector+1.2%+1.1% vs sector

On the reaction day the stock moved 1.5 pts more than Nifty 100 and 1.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.1

10m

+0.9

15m

+1.3

30m

+1.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.3+0.7+1.5+1.2+1.1

Next day

+3.9+1.0+2.9+3.1+0.7

+4.1pendingpending+4.8-0.7

—————

15d

—————

UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 174Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Zydus Lifesciences will announce financial results for Q2 FY27, covering July to September 2026, on November 4, 2026. A webinar will follow at 3:30 p.m. IST on the same day, hosted by Managing Director Dr. Sharvil Patel. Investors must pre-register to join. The earnings presentation, call audio, and transcript will be available on the company website.

Likely market impact

Results and management commentary may move the stock around November 4, but the filing provides no financial figures or outlook.